Mastodon

Hippopheae fructuum et foliorum oleum (Oil) Instructions for Use

Marketing Authorization Holder

Katun Oleum, LLC (Russia)

ATC Code

C05AX03 (Preparations for the treatment of hemorrhoids and anal fissures in combination)

Active Substance

Hippophaes oleum (Grouping name)

Dosage Form

Bottle OTC Icon Hippophaes oleum from fruits and leaves Oil for oral, topical, and external use: 50 ml or 100 ml bottle.

Dosage Form, Packaging, and Composition

Oil for oral, topical, and external use in the form of an oily orange-brown liquid with a characteristic odor; a slight sediment is allowed, which dissolves when heated to 40oC.

1 fl.
Sea buckthorn oil 100 %

50 ml – bottles (1) – cardboard packs.
100 ml – bottles (1) – cardboard packs.

Clinical-Pharmacological Group

Drug that activates tissue metabolism, improves trophism and stimulates the regeneration process

Pharmacotherapeutic Group

Tissue repair stimulant of plant origin

Pharmacological Action

A herbal remedy. It stimulates reparative processes in the skin and mucous membranes, accelerates the healing of damaged tissues.

It has a general strengthening effect, possesses antioxidant and cytoprotective action. It reduces the intensity of free radical processes and protects cellular and subcellular membranes from damage (due to the presence of fat-soluble bioantioxidants).

Indications

For oral and topical use: radiation injuries of the skin and mucous membranes; colpitis, endocervicitis, cervical erosion; gastric and duodenal ulcer, hyperacid gastritis, period after gastrointestinal tract surgery, atrophic pharyngitis, laryngitis, chronic colitis, nonspecific ulcerative colitis (as part of combination therapy).

For rectal use: hemorrhoids, anal fissures, rectal ulcers, proctitis, erosive-ulcerative sphincteritis and proctitis, catarrhal and atrophic proctitis, radiation injury of the mucous membrane of the lower colon.

For external use: scalped, postoperative, superficial burn wounds of II-IIIa degree (especially when preparing them for dermatoplasty), abrasions, trophic ulcers.

ICD codes

ICD-10 code Indication
J31.2 Chronic pharyngitis
J37.0 Chronic laryngitis
K25 Gastric ulcer
K26 Duodenal ulcer
K29.6 Other gastritis
K51 Ulcerative colitis
K52.0 Radiation gastroenteritis and colitis
K52.8 Other specified noninfective gastroenteritis and colitis
K60 Fissure and fistula of anus and rectum
K62.6 Ulcer of anus and rectum
K62.7 Radiation proctitis
K62.8 Other specified diseases of anus and rectum (including proctitis)
K64 Hemorrhoids and perianal venous thrombosis
L58 Radiation dermatitis
L98.4 Chronic skin ulcer, not elsewhere classified
N72 Inflammatory disease of cervix uteri (including cervicitis, endocervicitis, exocervicitis)
N76 Other inflammatory diseases of vagina and vulva
N86 Erosion and ectropion of cervix
T14.0 Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect)
T14.1 Open wound of unspecified body region
T30 Burns and corrosions of unspecified body region
Z54.0 Convalescence following surgery
ICD-11 code Indication
CA09.2 Chronic pharyngitis
CA0G Chronic laryngitis or laryngotracheitis
DA42.81 Radiation gastritis
DA42.Z Gastritis, unspecified
DA51.53 Radiation duodenitis
DA60.Z Gastric ulcer, unspecified
DA63.Z Duodenal ulcer, unspecified
DB33.41 Radiation colitis
DB33.42 Radiation proctitis
DB50.Z Fissure or fistula of anal region, unspecified
DB52 Ulcer of anus
DB6Z Hemorrhoids or perianal venous diseases, unspecified
DB70.Z Infections of anal and rectal regions, unspecified
DB72.Z Some specified diseases of the anal canal, unspecified
DD71.Z Ulcerative colitis, unspecified
DE2Z Diseases of the digestive system, unspecified
EA40 Tropical phagedenic ulcer
EF60 Ischemic ulceration of the skin
EG61 Infections of the anus or perianal skin
EH76.Y Other dermatoses associated with specific classes of drugs
EH92 Dermatoses provoked by friction or mechanical impact
EH92.1 Blister due to friction
EJ7Z Radiation-induced dermatoses, unspecified
EM0Z Unspecified skin disorder
GA00 Vulvitis
GA02.Z Unspecified vaginitis
GA0Z Inflammatory diseases of female genital tract, unspecified
GA15.1 Erosion or ectropion of cervix
ME60.2 Ulcerative skin lesion of unspecified nature
ND56.0 Superficial injury of unspecified body region
ND56.1 Open wound of unspecified body region
NE11 Burn of unspecified body region
QB7Y Other specified convalescence
GA0Z Inflammatory diseases of female genital tract, unspecified
XA5WW1 Cervix uteri

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer the oil orally, topically, or rectally as indicated by the specific condition.

For oral administration, take one teaspoon (5 ml) two to three times daily for gastric and duodenal ulcers, gastritis, and colitis.

Ingest the oil 30 minutes before meals; the treatment course typically lasts 3-4 weeks.

For topical use in gynecology, apply to affected cervical and vaginal areas after standard cleansing.

Use saturated tampons, applying them daily for 1-2 weeks or as directed for cervicitis and cervical erosion.

For rectal administration, use microclysters or soaked gauze tampons for hemorrhoids, anal fissures, and proctitis.

Introduce 5-10 ml of oil into the rectum once or twice daily after bowel evacuation; the treatment course is 10-15 days.

For external use, apply a thin layer to cleansed affected skin areas several times daily for wounds, burns, and ulcers.

Cover the treated area with a sterile gauze dressing; change dressings daily or as needed based on wound exudation.

Adjust the duration of treatment based on the severity of the condition and the observed therapeutic response.

Discontinue use and consult a physician if severe burning, signs of allergic reaction, or other adverse effects occur.

Adverse Reactions

Possible: allergic reactions; when taken orally – bitterness in the mouth, diarrhea; with external and rectal use – burning sensation.

Contraindications

Hypersensitivity to the drug; for oral use – cholecystitis, cholangitis, pancreatitis, hepatitis, cholelithiasis, children under 12 years of age; for rectal use – diarrhea.

Use in Pregnancy and Lactation

Use during pregnancy and breastfeeding is only possible if the intended benefit to the mother outweighs the potential risk to the fetus or child.

Pediatric Use

Contraindicated for oral use in children under 12 years of age.

Storage Conditions

Store at 2°C (36°F) to 8°C (46°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS